A nurse is assessing a 55-year-old male client who has been … | 마이메르시 MyMerci
Adult Health
문제

A nurse is assessing a 55-year-old male client who has been diagnosed with bladder cancer. Which assessment finding would be most characteristic of this condition?

해설
Painless hematuria is the most characteristic symptom of bladder cancer, occurring in about 85% of patients. Other symptoms like flank pain, frequency with burning, or oliguria are less specific.

심화 해설

Core Nursing Explanation Key Concept Analysis: This question tests the identification of the classic, hallmark symptom of Bladder cancer. The key is understanding that bladder cancer often presents with a specific, non-painful sign of bleeding, which distinguishes it from other common urinary tract conditions. The pathophysiology involves a tumor growing on the bladder wall, which is friable and bleeds easily into the urine, often without causing pain or irritation in the early stages.

Answer Rationale: Key Point! Painless hematuria is the single most common and characteristic initial symptom of bladder cancer. It is considered a "red flag" symptom that always warrants investigation. The bleeding is often intermittent, which can lead patients to dismiss it, delaying diagnosis. This symptom is present in the vast majority of cases.

Distractor Analysis:
Watch out for confusion! Flank pain radiating to the groin (Option 1) is the classic presentation of Renal colic due to a kidney stone (urolithiasis), not bladder cancer. While a bladder tumor could potentially cause obstruction, flank pain is not its characteristic finding.
Urinary frequency with burning sensation (Option 2) is highly indicative of a Urinary tract infection (UTI) or cystitis. While bladder cancer can sometimes cause irritative symptoms like frequency, the presence of a "burning sensation" points more strongly toward infection or inflammation, not the classic cancer presentation.
Oliguria with proteinuria (Option 4) points toward Renal dysfunction, such as in glomerulonephritis or chronic kidney disease (CKD). Oliguria (low urine output) is not a typical feature of localized bladder cancer.

Related Concepts: It's crucial for nurses to recognize that while painless hematuria is classic, bladder cancer can also present with other symptoms as it progresses, such as dysuria (painful urination), urgency, frequency, pelvic pain, or obstructive symptoms (difficulty urinating). However, for the NCLEX, the association of "painless hematuria = bladder cancer" is a high-yield link. Any report of hematuria, especially in a patient with risk factors like smoking, chemical exposure, or older age, requires prompt follow-up with cystoscopy.

Concept SummaryHallmark Sign: Painless, gross (visible) or microscopic hematuria. • Pathophysiology: Friable tumor vessels in the bladder mucosa bleed into urine. • Key Risk Factors: Smoking (biggest), occupational exposure to chemicals (e.g., dyes, rubber), chronic bladder inflammation, older age, male gender. • Diagnostic Gold Standard: Cystoscopy with biopsy.

Side-by-Side Comparison!
SymptomMost Likely ConditionKey Differentiator
Painless HematuriaBladder CancerBleeding without pain or infection signs.
Flank Pain Radiating to GroinKidney Stone (Nephrolithiasis)Severe, colicky pain; often with nausea/vomiting.
Dysuria, Frequency, UrgencyUrinary Tract Infection (UTI)Burning pain, often with cloudy/foul-smelling urine.
Oliguria & ProteinuriaGlomerulonephritis / CKDSigns of impaired kidney filtration function.

Anatomy, Physiology & Pharmacology PointsAnatomy: The bladder is a hollow muscular organ (detrusor muscle) lined with transitional epithelium (urothelium). Most bladder cancers (90%) are transitional cell carcinomas arising from this lining. • Physiology: Hematuria means red blood cells (RBCs) are present in the urine. "Gross" means visible to the naked eye (pink, red, cola-colored); "microscopic" means only seen under a microscope. • Pharmacology (Treatment Context): Intravesical therapy (e.g., BCG vaccine or chemotherapy like mitomycin C instilled directly into the bladder) is a common treatment for superficial bladder cancers to prevent recurrence.

Memory TipsMnemonic: "BLADDER Cancer": Bleeding (painless), Later symptoms (frequency, pain). Or simply: "Painless Pee with Blood = Think Bladder." • Association: Link the concept of a "painless" bleed to a tumor that isn't causing inflammation or obstruction yet—it's just a fragile mass that bleeds easily.

High-Frequency NCLEX Topics The NCLEX loves to test the classic presentation of diseases. Bladder cancer's "painless hematuria" is a prime example. You may also see questions on: 1. Priority nursing action for a patient reporting hematuria (e.g., notify provider, schedule cystoscopy). 2. Patient education for risk factor reduction (smoking cessation). 3. Post-procedure care after a transurethral resection of bladder tumor (TURBT), such as monitoring for bleeding, maintaining continuous bladder irrigation (CBI) if ordered, and teaching about possible pink-tinged urine.

Watch Out for Question Variations! • Instead of "most characteristic finding," the question could ask: "The nurse should instruct the client to report which finding immediately after a TURBT procedure?" Answer: Bright red blood or clots in the urine (indicative of hemorrhage). • Or: "A client with a history of bladder cancer reports new onset of flank pain. The nurse should suspect..." Answer: Possible ureteral obstruction by the tumor. • The scenario could shift to risk factors: "Which client is at greatest risk for bladder cancer?" (The smoker with a 40-pack-year history).

임상 시나리오

Nursing Clinical Practice Guide Clinical Scenario: Mr. Johnson, a 62-year-old retired painter with a 30-pack-year smoking history, comes to the clinic stating, "I saw some pink in the toilet a couple of times last month, but it went away. No pain or anything." He has no other urinary complaints.

Nursing Intervention Strategy: 1. Assessment: Perform a focused assessment. Document the characteristics of the hematuria (timing, color, pain association). Obtain a thorough history including smoking, occupational exposures, past UTIs, and family history. Perform a urinalysis (UA) and possibly a urine cytology test. 2. Nursing Diagnosis: Risk for ineffective health maintenance related to lack of follow-up for a warning sign; Anxiety related to possible cancer diagnosis. 3. Planning & Implementation: • Patient Education: Explain the significance of painless hematuria and the necessity for further testing (cystoscopy). Emphasize that intermittent bleeding does not mean the problem is gone. • Collaborative Care: Prepare the patient for diagnostic procedures. Reinforce teaching about cystoscopy: it's a scope inserted through the urethra to visualize the bladder, done under local or general anesthesia. • Support: Provide emotional support and clarify information from the urologist. 4. Evaluation: Evaluate patient understanding of the need for follow-up and his plan to undergo cystoscopy. Assess coping and anxiety levels.

Patient Safety and Precautions: • Never dismiss a report of hematuria, even if it's intermittent or "seems minor" to the patient. • After a TURBT procedure, monitor urine output and color closely. Report frank bleeding, clots causing obstruction, or signs of infection (fever, worsening pain). • For patients receiving intravesical BCG therapy, monitor for systemic side effects like fever, chills, or flu-like symptoms, which could indicate a serious reaction.

Nursing Procedure & Medication Flow Post-TURBT Care: 1. Maintain continuous bladder irrigation (CBI) if ordered to prevent clot formation. Monitor inflow and outflow rates; the outflow should be slightly less than inflow (accounting for urine production). Report if outflow stops (clot obstruction). 2. Monitor urine color: It should be light pink to clear. Report bright red blood. 3. Administer analgesics as ordered for bladder spasms (common after TURBT). 4. Educate: Pink-tinged urine is expected for several days. Avoid strenuous activity, heavy lifting. Increase fluid intake. Report fever, chills, or inability to void.

Intravesical Medication Administration: • The medication is instilled directly into the bladder via a catheter. • The patient must retain the medication in the bladder for 1-2 hours, changing position every 15-20 minutes to coat the entire bladder wall. • After the dwell time, the patient voids normally. For some drugs (like chemotherapy), special precautions are needed for handling the patient's urine for the next 24-48 hours.

A Word from Your Senior Nurse "Painless hematuria is one of those 'don't-miss' findings in nursing. In clinical practice, you are the one the patient tells, 'Oh, by the way, my urine was a little red last week.' Your knowledge and prompt action in escalating that finding can literally save a life by catching cancer early. When studying, lock in that link: bladder cancer = painless blood. But more importantly, understand the 'why'—the fragile tumor vessels. That deeper understanding will help you answer any twist the NCLEX throws at you and make you a vigilant advocate for your patients."

핵심 개념

  • Hematuria — The presence of red blood cells (RBCs) in the urine. Can be gross (visible) or microscopic. A key symptom requiring investigation.
  • Cystoscopy — The gold standard diagnostic procedure for bladder cancer. A thin scope is inserted through the urethra to directly visualize the interior of the bladder and obtain biopsies.
  • Transitional Cell Carcinoma — The most common type of bladder cancer (over 90%), arising from the transitional epithelium (urothelium) lining the urinary tract.
  • Transurethral Resection of Bladder Tumor — The primary surgical treatment for diagnosing, staging, and treating superficial bladder tumors. The tumor is removed using a resectoscope inserted through the urethra.
  • Intravesical Therapy — A treatment where medication (e.g., BCG immunotherapy or chemotherapy) is instilled directly into the bladder via a catheter to treat superficial cancers and prevent recurrence.

마이메르시로 국가고시 완벽 대비

기출문제와 상세 해설을 무료로. 내 약점을 분석하고 진도를 관리하며 더 똑똑하게 공부하세요.

무료로 시작하기

학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.